2024-11-15T07:51:19-05:00 2023-12-31 990 2023-01-01 222803458 MUSCULOSKELETAL TRANSPLANT FOUNDATION INC MUSC 7326610202 125 MAY STREET EDISON NJ 088373264 MICHAEL J KAWAS TREASURER/CFO 7326610202 2024-11-15 true 2023 2024-10-15 13:58:12Z MTFBIOLOGICS JOSEPH A YACCARINO 125 MAY ST EDISON NJ 08837 495463036 false X WWW.MTFBIOLOGICS.ORG X 1987 DC MTF IS A NONPROFIT ORG. THAT SAVES AND HEALS LIVES BY HONORING DONATED GIFTS AND SERVING PATIENTS, WE COLLABORATE WITH THE MEDICAL, SCIENTIFIC, AS WELL AS ORGAN AND TISSUE DONATION COMMUNITIES. CONTINUED ON SCHEDULE O. 10 9 1546 14 1198034 968850 1041165 466009432 481035486 16624402 2903118 7279260 8492044 490881944 493471813 1253326 1000849 0 139792388 146999247 0 0 328299953 340670098 469345667 488670194 21536277 4801619 324084626 323206971 219946619 212992800 104138007 110214171 X MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") IS DEDICATED TO PROVIDING QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS AND THEIR FAMILIES. MTF CONTINUES TO PROMOTE THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY (1) MAXIMIZING THE AVAILABILITY OF HIGH QUALITY HUMAN TISSUE INCLUDING BONE, DERMAL AND BIRTH TISSUE; 2) SUPPORTING MEDICAL, SCIENTIFIC AND OTHER EDUCATIONAL RESEARCH WITH RESPECT TO TISSUE DONATION, RECOVERY AND TRANSPLANTATION; AND(3) EDUCATING THE GENERAL PUBLIC WITH RESPECT TO THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION. MTF WAS INCORPORATED ON JANUARY 30, 1987, AS A DISTRICT OF COLUMBIA NON- PROFIT MEMBERSHIP ORGANIZATION AND IS A 501(C) (3)ORGANIZATION. THERE IS A CRITICAL NEED FOR MUSCULOSKELETAL, CARDIOVASCULAR, SKIN, BIRTH AND OCULAR TISSUE FOR TRANSPLANTATION. IN ORDER TO ACCOMPLISH MTF'S MISSION AND THESE ACTIVITIES, THE false false 461017053 1000849 481035486 MTF IS A GLOBAL NONPROFIT ORGANIZATION FOCUSED ON SAVING AND HEALING LIVES, EXPANDING INNOVATION POTENTIAL, HONORING DONATED GIFTS AND SERVING PATIENTS. MTF CONTINUES TO PROVIDE RESEARCH TISSUE AND GRANT FUNDING FOR RESEARCH AND DEVELOPMENT PERFORMED BY ACADEMIC CENTERS AND PIONEERING ENTERPRISES. IN 2023 MTF CONTINUED TO PURSUE ITS MISSION, AND MADE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS THROUGH BOTH INTERNAL AND EXTERNAL DISTRIBUTION RELATIONSHIPS. MTF ORTHOPEDICS FOSTERED NEW PARTNERSHIPS AND EXPANDED ITS REACH BY LAUNCHING MULTIPLE NEW TISSUE FORMS IN 2023. THESE INNOVATIONS POSITIONED THE FOUNDATION AND OUR PARTNERS TO HELP MORE PATIENTS, WHILE FURTHER MAXIMIZING THE GIFT OF DONATION. MTF ALSO IMPLEMENTED PROCESS EFFICIENCIES THAT WILL CONTINUE TO UTILIZE THE GIFT OF DONATION AND ALLOWS OUR SURGEON COLLABORATORS TO ELEVATE THEIR CONTINUUM OF CARE. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, MTF CONTINUED TO INNOVATE IN PLASTIC SURGERY, WHILE PROVIDING SURGEON EDUCATION AND TRAINING. CONTINUED FOCUS WAS PLACED ON PROCESSING EFFICIENCIES AND DONOR RECOVERY METHODS TO MAXIMIZE THE GIFT OF DONATION WITH THE HELP OF ORGAN PROCUREMENT ORGANIZATIONS. MTF CONTINUED TO BOLSTER ITS INTER-INDUSTRY PARTNERSHIPS, INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE DIVISION CONTINUED GROWING THROUGHOUT 2023, EXPANDING ITS PRESENCE IN THE WOUND HEALING SPACE. MTF GENERATED MORE CLINICAL EFFICACY DATA, AS WELL AS HEALTH CARE ECONOMIC DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY AND VALUE OF ITS TISSUE FORMS. OUR GOAL IS SIMPLE-DO WHAT'S RIGHT FOR PATIENTS, SURGEONS, TISSUE DONORS, AND THEIR FAMILIES THROUGH OUR GUIDING PRINCIPLES: WE TRANSFORM BY PROVIDING SAFE, HIGH-QUALITY GRAFTS FROM DONATED HUMAN TISSUES THAT ARE USED IN A GROWING ARRAY OF CLINICAL FIELDS. WE COLLABORATE BY FORGING RELATIONSHIPS WITH EXPERTS IN TISSUE AND ORGAN RECOVERY, AS WELL AS LEADING PHYSICIANS AND SCIENTISTS, TO ACCELERATE INNOVATION AND ENSURE THE BEST POSSIBLE EXPERIENCES AND OUTCOMES FOR PATIENTS. WE INNOVATE BY ADVANCING THE SCIENCE OF TRANSPLANTATION BY SUPPORTING RESEARCH WITHIN OUR OWN ORGANIZATION AND AMONG CLINICIANS AND RESEARCHERS WORLDWIDE. WE GIVE BACK BY REINVESTING IN RESEARCH TO POSITIVELY AFFECT LIVES ACROSS THE GLOBE. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 170,000 DONORS. IN 2023, MTF RECOVERED TISSUE FROM OVER 5,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 7,500 DONORS FOR USE IN GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 800 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 800 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED OVER 550,000 UNITS OF ALLOGRAFT TISSUE DURING 2023. MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS. 461017053 true true false true false false false false false false true false false true true true true true false true true false false false false false false true true true false false false false false false false false true false false false false true false true false true 326 0 true 1546 true true true true CA false false false false false false false false false false X 10 9 false false true false true true true true true false false true true true true true true true true false CA GA NJ X X MICHAEL J KAWAS 7326610202 125 MAY ST EDISON NJ 08837 JOSEPH A YACCARINO PRESIDENT/CE 60.00 X 863875 0 50685 MICHAEL J KAWAS TREASURER/CF 60.00 X 673909 0 33219 MARC LONG EXEC R & D 60.00 X 491568 0 51235 JENNIFER BIRMINGHAM SECRETARY/GE 60.00 X 487128 0 51235 SARAH BRUSCH SURGICAL CON 50.00 X 479204 0 45010 GEORGE HERRERA EXEC VP DONO 60.00 X 459361 0 51185 MICHAEL OLECK EXEC VP OPS 60.00 X 454835 0 42389 BRIAN LEUTHNER VP PRS 50.00 X 410768 0 46821 AMANDA BLAKEMAN SURGICAL CON 50.00 X 402872 0 40265 KEITH MOROCKO VP CONTRACT 50.00 X 394947 0 47933 MICHAEL ROGERS SURGICAL CON 50.00 X 409134 0 28551 KIMBERLY A ROUNDS VP WOUND CAR 50.00 X 411434 0 19800 BRADLEY BAILEY VP ORTHOPEDI 50.00 X 384828 0 44452 CALEB CHAMBERLAYN SURGICAL CON 50.00 X 395892 0 32706 MARTHA ANDERSON FORMER EXEC X 193502 0 6514 THOMAS C SHAFFER FORMER EXEC X 169056 0 8141 WILLIAM W TOMFORD MD DIRECTOR 4.00 X 75000 0 0 DONALD HACKBARTH MD DIRECTOR 1.00 X 35000 0 0 DAVID KULBER MD DIRECTOR 1.00 X 32250 0 0 JOSEPH D ZUCKERMAN MD DIRECTOR 1.00 X 30000 0 0 SYMERIA T HUDSON DIRECTOR 1.00 X 28750 0 0 JOSEPH A BUCKWALTER MD DIRECTOR 1.00 X 27500 0 0 SHARON GABRIELSON DIRECTOR 1.00 X 25000 0 0 JAN FINN DIRECTOR 1.00 X 0 0 0 ALLAN GROSS MD NON-VOTING D 1.00 X 0 0 0 GERALD FINERMAN MD NON-VOTING D 1.00 X 0 0 0 DAVID R MCALLISTER MD DIRECTOR 1.00 X 0 0 0 JEFFREY P ORLOWSKI DIRECTOR 1.00 X 0 0 0 7335813 600141 355 true true false ORTHOFIX SPINAL IMPLANTS 3451 PLANO PARKWAY LEWISVILLE TX 75056 TISSUE PROMO 53241201 CONMED LINVATEC 1250 TERMINUS DRIVE LITHIA SPRINGS GA 30122 TISSUE PROMO 30833800 DEPUY SYNTHES SALES 1302 WRIGHTS LANE EAST WEST CHESTER PA 19380 TISSUE PROMO 27688343 CENTURION THERAPEUTICS PO BOX 175 MARSHFIELD HILLS MA 02051 8654589 KOLOSIS BIO 333 S RIO GRANDE ST SALT LAKE CITY UT 84101 TISSUE PROMO 8519706 215 1041165 1041165 TISSUE PROCESSING & DISTRIB. 621991 466175751 466175751 DONOR SCREENING 561421 8015936 8015936 DISTRIBUTION RIGHTS PAYMENTS 900099 6843799 6843799 481035486 2903118 2903118 101981 101981 3189257 1991223 1198034 1198034 DISTRIBUTION PARTNER REVENUE 900099 4004782 4004782 PARTNER REVENUE 900099 1303320 1303320 FREIGHT & DELIVERY REVENUE 900099 1252242 1252242 631685 631685 7192029 493471813 481035486 1198034 10197128 985699 985699 15150 15150 4891204 3260802 1630402 362558 52194 310364 109598454 96904214 12694240 5152206 4287470 864736 19432415 16286423 3145992 7562410 6297876 1264534 1039679 922357 117322 386286 386286 944428 472693 471735 2530807 2456943 73864 1206070 406578 799492 964895 616100 348795 4049996 4049996 11294638 10276221 1018417 3370935 3116282 254653 4140631 3477792 662839 847368 847368 4773066 3798041 975025 1348468 1128731 219737 STORAGE & DISTRIBUTION 148180749 148180749 PROCESSING COSTS 120014065 120014065 RECOVERY EXPENSES 13251578 13251578 RESEARCH AND DEVELOPMENT 6486083 6486083 15840356 13425648 2414708 488670194 461017053 27653141 0 42675428 67145530 68262429 66588579 110701962 101069887 2204656 2511719 134690264 98925979 35802690 35764285 3962500 4060000 60474961 46066971 324084626 323206971 66409619 65882508 3126341 2828492 92442472 85898673 12400000 14347641 45568187 44035486 219946619 212992800 X 104138007 110214171 104138007 110214171 324084626 323206971 X 4801619 1274545 X false true X true false X 890250 874610 929119 968850 1041165 4703994 452689157 412031487 454446555 466009432 481035486 2266212117 6886071 5549236 6852331 7242719 7192029 33722386 460465478 418455333 462228005 474221001 489268680 2304638497 2304638497 1827599 553522 149157 338308 3005099 5873685 1827599 553522 149157 338308 3005099 5873685 254880 1197034 1451914 462293077 419008855 462632042 474559309 493470813 2311964096 0.99680 0.99780 0.00000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false false false true 40000 40000 false SCHEDULE C, PART II-B, LINE 1 MTF DOES NOT MAKE POLITICAL CAMPAIGN DONATIONS. THE ORGANIZATION INDIRECTLY PARTICIPATED IN LOBBYING ACTIVITIES THROUGH MEMBERSHIP FEES PAID TO THE AMERICAN ASSOCIATION OF TISSUE BANK'S TISSUE POLICY GROUP. 6467468 6467468 59152274 44696433 14455841 50203773 38932604 11271169 18866749 15296942 3569807 35764285 RIGHT OF USE ASSETS 30474124 AFFILIATE RECEIVABLE 14812181 SECURITY DEPOSITS 440666 OTHER 340000 46066971 LEASE LIABILITY 30649719 OTHER 8030806 DUE TO AFFILIATES 3423988 PARTNER ADVANCE 1930973 44035486 X 494658176 1186363 1186363 493471813 493471813 488582012 488582012 88182 88182 488670194 SCHEDULE D, PAGE 3, PART X MTF FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. MTF HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX- EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. MTF HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2023. SCHEDULE D, PAGE 4, PART XI, LINE 2D UNREALIZED FOREIGN EXCHANGE 1,186,363 SCHEDULE D, PAGE 4, PART XII, LINE 4B GRANTS PAID 88,182 false EUROPE 1 PROGRAM SERVICES TISSUE DISTRIBUTION 2868071 NORTH AMERICA 1 PROGRAM SERVICES TISSUE DISTRIBUTION 2686562 EAST ASIA AND THE PACIFIC 1 PROGRAM SERVICES TISSUE DISTRIBUTION 8416967 CENTRAL AMERICA & CARIBBEAN 1 PROGRAM SERVICES TISSUE DISTRIBUTION 214499 MIDDLE EAST & NORTH AFRICA 1 PROGRAM SERVICES TISSUE DISTRIBUTION 552800 SOUTH AMERICA 1 PROGRAM SERVICES TISSUE DISTRIBUTION 888287 SOUTH ASIA 1 PROGRAM SERVICES TISSUE DISTRIBUTION 18018 SUB-SAHARAN AFRICA 1 PROGRAM SERVICES TISSUE DISTRIBUTION 25298 8 8 15670502 15670502 true false false false false false SCHEDULE F, PAGE 1, PART I, LINE 3 EUROPE 2,868,071 0 NORTH AMERICA 2,686,562 0 EAST ASIA AND THE PACIFIC 8,416,967 0 CENTRAL AMERICA & CARIBBEAN 214,499 0 MIDDLE EAST & NORTH AFRICA 552,800 0 SOUTH AMERICA 888,287 0 SOUTH ASIA 18,018 0 SUB-SAHARAN AFRICA 25,298 0 true ARIZONA STATE UNIVERSITY FOUNDATION 300 E UNIVERSITY DR 6TH FLOOR TEMPE AZ 852812061 866051042 501C3 37500 SCIENTIFIC RESEARCH BRIGHAM AND WOMEN'S HOPSITAL 75 FRANCIS STREET BOSTON MA 02115 042312909 501C3 25000 SCIENTIFIC RESEARCH CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVENUE CLEVELAND OH 441067222 341018992 501C3 93750 SCIENTIFIC RESEARCH CEDARS SINAI MEDICAL CENTER 8700 BEVERLY BLVD 65-WIL SUITE 11 LOS ANGELES CA 900481804 951644600 501C3 40887 SCIENTIFIC RESEARCH CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BLVD 65-WIL SUITE 11 LOS ANGELES CA 900481804 951644600 501C3 50000 SCIENTIFIC RESEARCH CLEMSON UNIVERSITY RESEARCH FOUNDAT PO BOX 946 CLEMSON SC 296330946 570750000 501C3 25000 SCIENTIFIC RESEARCH FEINSTEIN INSTITUTES FOR MEDICAL RE 1991 MARCUS AVE SUITE 102 LAKE SUCCESS NY 11042 112673595 501C3 60885 SCIENTIFIC RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICK RD BALTIMORE MD 21211 520595110 501C3 50000 SCIENTIFIC RESEARCH NEW JERSEY INSTITUTE OF TECHNOLOGY 323 MARTIN LUTHER KING BLVD NEWARK NJ 071021982 226000910 501C3 24852 SCIENTIFIC RESEARCH OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK RD PORTLAND OR 972013098 931176109 501C3 24899 SCIENTIFIC RESEARCH ORTHOPAEDIC RESEARCH AND EDUCATION 9400 WEST HIGGINS ROAD SUITE 215 ROSEMONT IL 600184975 366009467 501C3 110000 SCIENTIFIC RESEARCH REGENTS OF THE UNIVERSITY OF CA LO 10833 LECONTE AVENUE BOX 956902 LOS ANGELES CA 90095 956006143 501C3 75000 SCIENTIFIC RESEARCH THE BOARD OF TRUSTEES OF THE UNIVER 28395 NETWORK PLACE CHICAGO IL 606731283 376000511 501C3 41666 SCIENTIFIC RESEARCH THE CURATORS OF THE UNIVERSITY OF M 115 BUSINESS LOOP 70 WEST COLUMBIA MO 652110001 436003859 501C3 87499 CAREER DEVELOPMENT TRUSTEES OF BOSTON UNIVERSITY 72 EAST CONCORD STREET EVANS 243 BOSTON MA 02118 042103547 501C3 41667 SCIENTIFIC RESEARCH UNIVERSITY OF CINCINNATI PO BOX 210222 CINCINNATI OH 452210222 316000989 501C3 50000 SCIENTIFIC RESEARCH UNIVERSITY OF GEORGIA 310 E CAMPUS ROAD ATHENS GA 30602 581353149 501C3 15844 SCIENTIFIC RESEARCH UNIVERSITY OF MICHIGAN 930 N UNIVERSITY AVE ANN ARBOR MI 48108 386006309 501C3 58333 SCIENTIFIC RESEARCH UNIVERSITY OF OREGON PO BOX 3237 EUGENE OR 974030237 464727800 501C3 56250 SCIENTIFIC RESEARCH UNIVERSITY OF ROCHESTER 910 GENESEE STREET ROCHESTER NY 14611 160743209 501C3 16667 SCIENTIFIC RESEARCH 20 STIPENDS FOR GRANT REVIEW 15150 SCHEDULE I, PAGE 1, PART I, LINE 2 GRANTEE QUALIFICATIONS: GRANTS ARE AWARDED BY THE BOARD OF DIRECTORS IN THE FOLLOWING CATEGORIES: 1)ORTHOPEDIC RESEARCH GRANT: AWARDED THROUGH THE OREF (ORTHOPEDIC RESEARCH & EDUCATION FOUNDATION). THIS AWARD IS FOR RESEARCH RELATING TO ALLOGRAFT SCIENCE. THE PURPOSE IS TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP, AND ENCOURAGE INVESTIGATIVE KNOWLEDGE OF THE CAUSES, CURE, AND PREVENTION OF ORTHOPEDIC RELATED INJURIES AND CONDITIONS, AND TO ENCOURAGE RESEARCH IN THE FIELD OF ORTHOPEDIC SURGERY IN THE MUSCULOSKELETAL SYSTEM THROUGH THE AWARDING OF RESEARCH AND EDUCATIONAL GRANTS. 2)PEER-REVIEW GRANTS: CLINICAL, SCIENTIFIC, AND TRANSLATIONAL RESEARCH GRANTS ARE AWARDED FOR THE CONTINUED RESEARCH TO DESIGN AND SUPPORT THE ADVANCEMENT OF ALLOGRAFT SCIENCE TO BOTH MEMBER AND NON-MEMBER ACADEMIC INSTITUTIONS. THERE ARE TWO LEVELS OF THIS TYPE OF GRANT: A) JUNIOR INVESTIGATOR AWARDS FOR NEW PRINCIPAL RESEARCHERS ARE AVAILABLE FOR UP TO 75,000 EACH FOR ONE YEAR, NON-RENEWABLE AND B) ESTABLISHED INVESTIGATOR AWARDS FOR EXPERIENCED PRINCIPAL RESEARCHERS ARE AVAILABLE FOR UP TO 83,333 EACH PER YEAR FOR UP TO THREE YEARS. IN ADDITION, PEER REVIEW GRANTS ARE SUBJECT TO REVIEW AND EVALUATED FOR QUALITY BY INDEPENDENT GRANT REVIEWERS. 3)ACADEMIC CAREER DEVELOPMENT: THIS AWARD IS INTENDED TO FOSTER THE DEVELOPMENT OF OUTSTANDING CLINICIANS AND ENABLE THEM TO EXPAND THEIR POTENTIAL TO MAKE SIGNIFICANT RESEARCH CONTRIBUTIONS TO THEIR CLINICAL FIELD. ONLY APPLICANTS FROM FOUNDATION MEMBER INSTITUTIONS ARE ELIGIBLE. AWARDS ARE FOR UP TO 83,333 EACH PER YEAR FOR UP TO THREE YEARS. RECIPIENTS OF MTF PEER REVIEW AND ACADEMIC CAREER DEVELOPMENT GRANT AWARDS WILL RECEIVE THEIR SUPPORT MADE IN INSTALLMENT PAYMENTS DURING THE GRANT PERIOD, WHICH MAY BE AS LONG AS SEVERAL YEARS. THE FINAL INSTALLMENT PAYMENT WILL BE MADE UPON RECEIPT OF A FINAL RESEARCH REPORT. A DETAILED BUDGET SHOWING USE OF ALL FUNDS AWARDED IS ALSO REQUIRED AS PART OF THE REPORT MADE TO MTF PRIOR TO THE RELEASE OF THE FINAL INSTALLMENT. TWO 6- MONTH, NO COST EXTENSIONS OF THE GRANT MAY BE FORMALLY REQUESTED. IF THE GRANT IS NOT COMPLETED BY THE AGREED COMPLETION DATE, THE GRANTEE WILL LOSE THE REMAINING INSTALLMENT OF THE GRANTED FUNDS. UNUSUAL CIRCUMSTANCES WILL BE CONSIDERED. 4)GRANT REVIEWER STIPENDS: GRANT REVIEWER STIPENDS ARE PAID TO INDEPENDENT REVIEWERS FOR REVIEWING AND EVALUATING FOR QUALITY THE PEER REVIEW AND ACADEMIC CAREER DEVELOPMENT GRANT PROPOSALS. 5)MTF BOD DIRECTED RESEARCH: PROJECTS DISCUSSED, AUTHORIZED, AND INITIATED BY THE BOARD OF DIRECTORS. INDIVIDUALS FROM ANY ACCREDITED INSTITUTION MAY QUALIFY FOR THIS TYPE OF GRANT. INDIVIDUAL AMOUNTS VARY BASED ON THE BUDGET NECESSARY TO CONCLUDE THE RESEARCH INITIATIVE. 6) PLASTIC AND RECONSTRUCTIVE SURGERY RESEARCH GRANT: AWARDED THROUGH THE PSF (THE PLASTIC SURGERY FOUNDATION). THIS AWARD IS FOR RESEARCH RELATING TO BIOLOGIC RECONSTRUCTION IN PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE. THE PURPOSE IS TO FOSTER, PROMOTE, SUPPORT, AUGMENT, DEVELOP, AND ENCOURAGE INVESTIGATIVE KNOWLEDGE OF THE CAUSES, CURE, AND PREVENTION OF INJURIES AND CONDITIONS IN THE FIELDS OF PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE, AND TO ENCOURAGE RESEARCH IN ALLOGRAFT SCIENCE IN THE FIELDS PLASTIC AND RECONSTRUCTIVE SURGERY AND WOUND CARE THROUGH THE AWARDING OF RESEARCH AND EDUCATIONAL GRANTS. ORGANIZATIONS FROM ANY ACCREDITED INSTITUTION MAY QUALIFY FOR THIS GRANT. 100,000 (MAXIMUM) EACH. X X X X X true false false false false false false true false JOSEPH A YACCARINO PRESIDENT/CEO 659467 191580 12828 19800 33930 914560 MICHAEL J KAWAS TREASURER/CFO 545316 120820 7773 19800 16464 707128 MARC LONG EXEC R & D 401230 87500 2838 19800 34480 542803 JENNIFER BIRMINGHAM SECRETARY/GEN COUNSL 395200 90410 1518 19800 34480 538363 SARAH BRUSCH SURGICAL CONSULTANT 87524 391323 357 11275 34524 524214 GEORGE HERRERA EXEC VP DONOR SRVS 373120 82790 3451 19800 34430 510546 MICHAEL OLECK EXEC VP OPS 368063 78390 8382 19800 25634 497224 BRIAN LEUTHNER VP PRS 332560 75370 2838 15386 34484 457589 AMANDA BLAKEMAN SURGICAL CONSULTANT 77784 324874 214 11880 29121 443137 KEITH MOROCKO VP CONTRACT ADMIN 318296 75110 1541 17048 33221 442880 MICHAEL ROGERS SURGICAL CONSULTANT 74595 334374 165 16782 12453 437685 KIMBERLY A ROUNDS VP WOUND CARE 338246 71670 1518 19800 2435 431234 BRADLEY BAILEY VP ORTHOPEDICS 313840 69320 1668 16067 30753 429280 CALEB CHAMBERLAYN SURGICAL CONSULTANT 83856 311896 140 4840 28653 428598 MARTHA ANDERSON FORMER EXEC VP 193502 6514 200016 THOMAS C SHAFFER FORMER EXEC VP 169056 8141 177197 SCHEDULE J, PAGE 1, PART I, LINE 4 MARTHA ANDERSON 141,308 0 0 THOMAS C. SHAFFER 169,056 0 0 SCHEDULE J, PAGE 1, PART I, LINE 7 NON-FIXED MONETARY AMOUNTS ARE CONTINGENT UPON DISCRETIONARY FACTORS INCLUDING THE PROGRAM SERVICE ACCOMPLISHMENTS OF THE FOUNDATION AND THE CURRENT MARKET CONDITIONS. THE COMPENSATION COMMITTEE OF THE FOUNDATION'S BOARD OF DIRECTORS HAS THE PRIMARY RESPONSIBILITY OF REVIEWING AND APPROVING THE NON-FIXED COMPENSATION OF THE FOUNDATION'S CEO AND OTHER NAMED EXECUTIVE OFFICERS. X TISSUE FORMS 10112 false false false SCHEDULE M, PAGE 2, PART II PART I, LINE 33 - EXPLANATION FOR NOT REPORTING REVENUE FORM 990 SCHEDULE M - ALLOGRAFT TISSUE DONATION FORM 990 THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") RECOVERS, PROCESSES AND/OR DISTRIBUTES DONATED HUMAN TISSUES FOR TRANSPLANT, EDUCATION AND RESEARCH PURPOSES. THESE TISSUES INCLUDE MUSCULOSKELETAL TISSUES (E.G., BONE, TENDON, LIGAMENT, AND CARTILAGE) AND DERMAL TISSUES, BIRTH TISSUE, AND NON-TRANSPLANTABLE ORGANS (E.G., LIVERS, HEARTS, LUNGS; WHICH ARE USED SOLELY FOR RESEARCH PURPOSES). ALL ORGANS AND TISSUES ARE DONATED ACCORDING TO ESTABLISHED STATE AND FEDERAL LAWS AND REGULATIONS, INCLUDING THE NATIONAL ORGAN TRANSPLANT ACT AND UNIFORM ANATOMICAL GIFT ACT. NO REMUNERATION IS PROVIDED TO THE DONOR OR THEIR FAMILY FOR THE DONATION. TISSUES ARE RECOVERED EITHER DIRECTLY BY THE FOUNDATION OR BY AFFILIATED ORGANIZATIONS (E.G., ORGAN PROCUREMENT ORGANIZATIONS, EYE AND TISSUE BANKS) THAT THE FOUNDATION HAS FORMAL WRITTEN AGREEMENTS. COSTS ASSOCIATED WITH THE RECOVERY PROCESS ARE REIMBURSED BY THE FOUNDATION TO THE AFFILIATED ORGANIZATIONS. NO VALUE IS ASSIGNED TO THE DONATED TISSUES OR ORGANS. THE COSTS ASSOCIATED WITH RECOVERY, PROCESSING AND DISTRIBUTION ARE CAPITALIZED WHEN INCURRED. THIS VALUE IS THE BASIS OF INVENTORY AVAILABLE FOR TRANSPLANTATION AND/OR RESEARCH. THE FOUNDATION THEN CHARGES A SERVICE FEE FOR THE COSTS ASSOCIATED WITH THE RECOVERY, PREPARATION, STORAGE, AND DISTRIBUTION OF THE TISSUES. FORM 990 - ORGANIZATION'S MISSION MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") IS DEDICATED TO PROVIDING QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS AND THEIR FAMILIES. MTF CONTINUES TO PROMOTE THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY (1) MAXIMIZING THE AVAILABILITY OF HIGH QUALITY HUMAN TISSUE INCLUDING BONE, DERMAL AND BIRTH TISSUE; 2) SUPPORTING MEDICAL, SCIENTIFIC AND OTHER EDUCATIONAL RESEARCH WITH RESPECT TO TISSUE DONATION, RECOVERY AND TRANSPLANTATION; AND(3) EDUCATING THE GENERAL PUBLIC WITH RESPECT TO THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION. MTF WAS INCORPORATED ON JANUARY 30, 1987, AS A DISTRICT OF COLUMBIA NON- PROFIT MEMBERSHIP ORGANIZATION AND IS A 501(C) (3)ORGANIZATION. THERE IS A CRITICAL NEED FOR MUSCULOSKELETAL, CARDIOVASCULAR, SKIN, BIRTH AND OCULAR TISSUE FOR TRANSPLANTATION. IN ORDER TO ACCOMPLISH MTF'S MISSION AND THESE ACTIVITIES, THE FOUNDATION MAINTAINS A DONOR RECOVERY NETWORK, SUPPORTS DONOR AWARENESS PROGRAMS FOR THE PUBLIC, DONATES BONE AND OTHER TISSUE FOR RESEARCH, PROVIDES RESEARCH GRANTS, AND OTHERWISE SUPPORTS BONE, SKIN, WOUND CARE AND CARDIOVASCULAR TISSUE TRANSPLANTATION, RESEARCH AND EDUCATIONAL PROGRAMS. THE FOUNDATION'S MEMBERSHIP IS COMPRISED OF 501(C)(3) NON-PROFIT ORGANIZATIONS. THE MEMBERSHIP CONSISTS OF FORTY-TWO ACADEMIC MEMBERS (ORTHOPEDIC TEACHING INSTITUTIONS), THIRTY-ONE RECOVERY ORGANIZATIONS (ORGAN, EYE AND TISSUE PROCUREMENT ORGANIZATIONS) THROUGHOUT THE UNITED STATES. BIOCON, INC., A NON-PROFIT 501(C)(3) ORGANIZATION, SERVES AS THE SOLE CORPORATE MEMBER OF THE FOUNDATION. THE FOUNDATION'S NATIONWIDE DONOR RECOVERY NETWORK IS BASED ON ITS AFFILIATION WITH ITS RECOVERY AND REFERRING MEMBERS. THIS NATIONAL NETWORK ALLOWS THE PUBLIC TO QUICKLY ACCESS NEEDED ALLOGRAFT TISSUE. BONE AND OTHER ALLOGRAFT TISSUE RECOVERED THROUGH THIS NETWORK IS SUBJECT TO STANDARDIZED SCREENING CRITERIA FOR DONATION ESTABLISHED BY THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND DONATION BOARD OF TRUSTEES (DESCRIBED BELOW). THE FOUNDATION ALSO MAINTAINS A QUALITY ASSURANCE PROGRAM WITH RESPECT TO ALLOGRAFT TISSUES RECOVERED THROUGH THE NETWORK. THIS QUALITY PROGRAM IS BASED ON THE POLICIES ADOPTED BY THE AMERICAN ASSOCIATION OF TISSUE BANKS AND THE REGULATIONS PUBLISHED BY THE FOOD & DRUG ADMINISTRATION AND OTHER REGULATORY AGENCIES OUTSIDE THE U.S WHERE THE FOUNDATION DISTRIBUTES TISSUE. THE FOUNDATION PROVIDES RECOVERY ORGANIZATION MEMBERS AND THE GENERAL COMMUNITY THEY SERVE WITH FUNDING FOR HOSPITAL DEVELOPMENT AND DONOR AWARENESS SERVICES. THESE SERVICES ALSO INCLUDE PROVIDING TRAINING TO RECOVERY ORGANIZATION MEMBERS, EDUCATIONAL SYMPOSIUMS TO BOTH RECOVERY ORGANIZATION MEMBERS AND HOSPITAL STAFF, AND EDUCATIONAL MATERIALS FOR USE IN SEMINARS TO HOSPITAL PROFESSIONALS AND THE GENERAL PUBLIC. AS INDICATED IN ARTICLE III OF THE FOUNDATION'S BYLAWS, A MEMBER OF THE FOUNDATION CAN BE AN ACADEMIC MEDICAL INSTITUTION WITH AN ACCREDITED RESIDENCY TRAINING PROGRAM; A FEDERALLY CHARTERED OPO; OR AN EYE/TISSUE BANK. ALL MEMBERS AGREE TO SUPPORT THE FOUNDATION'S MISSION EITHER THROUGH A SERVICES AND SUPPLY AGREEMENT OR SERVICES AND RECOVERY AGREEMENT. SOME MEMBERS ARE ELIGIBLE FOR RESEARCH FUNDING (SEE SCHEDULE I, PT. IV FOR GRANT PROGRAM OVERVIEW) FROM THE FOUNDATION UPON RECOMMENDATION AND/OR APPROVAL OF EITHER THE BOARD OF DIRECTORS OR THE MEDICAL BOARD OF TRUSTEES. ALTHOUGH ALL OF THE FOUNDATION'S MEMBERS ARE NON-PROFIT 501(C) (3) ORGANIZATIONS, THE FOUNDATION MAKES ITS TRANSPLANTATION TISSUE NETWORK AND PROGRAMS AVAILABLE TO ANY PERSON OR ORGANIZATION (TYPICALLY THROUGH THEIR HOSPITALS AND PHYSICIANS)IN NEED OF ALLOGRAFT TISSUE. THE FOUNDATION FUNDS ALL COSTS ASSOCIATED WITH THE RECOVERY OF DONOR TISSUES. IT SUPPORTS THESE COSTS WITH FEES INTENDED TO COVER ITS EXPENSES (INCLUDING FUNDING FOR RESEARCH) FROM THE USER OF THE TISSUE. THE FOUNDATION WILL MAKE SUCH TISSUE AVAILABLE AT A REDUCED FEE OR NO CHARGE FOR VARIOUS CAUSES INCLUDING TRANSPLANTATION AND FOR PURPOSES OF RESEARCH BY 501(C)(3) ORGANIZATIONS. ALL FUNDS REALIZED BY THE FOUNDATION ARE USED TO COVER THE COSTS OF ITS PROGRAM ACTIVITIES (INCLUDING OVERHEAD)WITH ANY SURPLUS APPLIED TOWARDS SUBSIDIZING THE COSTS OF THOSE IN NEED OF TISSUE WHO ARE UNABLE TO AFFORD IT, TO FUND EDUCATION AND RESEARCH, TO MAINTAIN THE APPROPRIATE INFRASTRUCTURE AND/OR TO BUILD UP RESERVES NEEDED TO MAINTAIN AND EXPAND THE FOUNDATION'S PROGRAMS. WHILE THE FOUNDATION'S ACTIVITIES ARE MONITORED BY ITS MEMBERS, THE FOUNDATION HAS A TWELVE PERSON BOARD OF DIRECTORS AND TWO NON-VOTING EMERITUS MEMBERS. THIS BOARD IS COMPRISED PRIMARILY OF WORLD RENOWN EXPERTS FROM THE NON-PROFIT HEALTHCARE COMMUNITY HAVING VARIOUS SCIENTIFIC, TRANSPLANT, AND MEDICAL SPECIALTIES. THE BOARD OF DIRECTORS HAS ULTIMATE RESPONSIBILITY TO MANAGE THE FOUNDATION. OF THE BOARD'S 12 VOTING MEMBERS, THERE ARE TWO MEMBERS EACH FROM THE MEDICAL BOARD AND THE DONATION BOARD OF TRUSTEES. SERVING IN TANDEM WITH OTHER BOARD OF DIRECTORS, THE FOUNDATION HAS A MEDICAL BOARD OF TRUSTEES (THE "MEDICAL BOARD") AND A DONATION BOARD OF TRUSTEES ("DONATION BOARD"). THE MEDICAL BOARD IS COMPRISED OF RESPECTIVE PHYSICIANS FROM ORTHOPEDIC AND PLASTIC SURGERY DEPARTMENTS OF THE ACADEMIC INSTITUTION MEMBERS OF THE FOUNDATION, PLUS ADDITIONAL PERSONS WHO HAVE SPECIFIC EXPERTISE PERTAINING TO TRANSPLANTATION ETHICS AND RESEARCH ACTIVITIES WITHIN THE INDUSTRY. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE MEDICAL BOARD ARE DETAILED IN ARTICLE IV, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL IT PROVIDES THAT THE MEDICAL BOARD SHALL ADVISE THE FOUNDATION WITH RESPECT TO OPTIMIZING THE DISTRIBUTION OF RESEARCH GRANTS, THE CHOICE OF AREAS MERITING RESEARCH FUNDING, AND ESTABLISHING THE STANDARD POLICIES AND PROTOCOLS RELATING TO THE SCREENING, RECOVERY, TRANSPORT, TESTING, PROCESSING, STORAGE AND DISTRIBUTION OF TRANSPLANTABLE BONE AND TISSUE. THE DONATION BOARD IS COMPRISED OF INDIVIDUALS KNOWLEDGEABLE IN THE FIELD OF TISSUE DONATION AND RECOVERY AND ARE LEADERS OF THE FOUNDATION'S RECOVERY ORGANIZATION MEMBERSHIP. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE DONATION BOARD ARE DETAILED IN ARTICLE VI, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL THE DONATION BOARD PROVIDES THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT OF THE FOUNDATION WITH RECOMMENDATIONS WITH REGARD TO TISSUE DONATION PRACTICES SUCH AS SCREENING, RECOVERY, AND TESTING CRITERIA. THE FOUNDATION SUPPORTS EDUCATIONAL, SCIENTIFIC AND RESEARCH PROJECTS BY DISTRIBUTING FUNDS AND MAKING AVAILABLE, AT NO CHARGE, DONATED TISSUE FOR RESEARCH. THE FOUNDATION FUNDS MANY TYPES OF PROJECTS RELATED TO ADVANCING TRANSPLANT SCIENCE. ACCORDINGLY, GRANTS ARE PROVIDED FOR PROJECTS IN TISSUE DONATION AND APPLICATION. IN SUM, ALL OF THE ACTIVITIES OF THE FOUNDATION HAVE BEEN AND WILL BE DIRECTED AT MEETING THE NEEDS OF THE GENERAL PUBLIC FOR ALLOGRAFT TISSUE AND/OR IMPROVING THE MANNER IN WHICH TRANSPLANT TISSUE IS MADE AVAILABLE TO THE GENERAL PUBLIC. ADDITIONALLY, THE FOUNDATION SUPPORTS RESEARCH TO ADVANCE THE SCIENCE OF MUSCULOSKELETAL AND OTHER TISSUE APPLICATIONS. THE FOUNDATION OFFERS EDUCATIONAL SERVICE TO SURGEONS AND NURSES BY WAY OF CONTINUING MEDICAL EDUCATION (CME) AND CONTACT HOUR PROGRAMS. IN ADDITION, THE FOUNDATION PROVIDES EDUCATION THROUGH A SPEAKER PROGRAM IN CONJUNCTION WITH ORTHOPEDIC TEACHING HOSPITALS ACROSS THE UNITED STATES. SURGEONS UTILIZE THE FOUNDATION'S ALLOGRAFT FORMS DURING PROCEDURAL TRAINING OR CADAVERIC SPECIMENS DURING CME COURSES. FORM 990, PAGE 1, PART I, LINE 6 COMPASSIONATE CARE FOR DONOR FAMILIES IS AT THE HEART OF OUR MISSION AT MTF THE DONOR FAMILY SUPPORT SERVICES VOLUNTEERS NEVER FORGETS THE MAGNITUDE OF THE GIFT OUR DONORS AND THEIR FAMILIES MAKE. WE'VE SET THIS SITE UP JUST FOR YOU, A PLACE YOU CAN COME TO LEARN ABOUT TISSUE DONATION, FIND HELPFUL RESOURCES AND MORE. WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS-COMMUNITY/DONORS-FAMILIES OUR VOLUNTEERS ARE THERE TO HELP YOU COPE WITH YOUR LOSS, WHILE APPRECIATING THE INCREDIBLE GIFT YOUR LOVED ONE HAS MADE TO OTHERS INCLUDING PERIODIC PERSONAL PHONE CALLS, REMEMBRANCES INCLUDING SYMPATHY CARDS, FREE INFORMATIVE PACKET WITH BEREAVEMENT SUPPORT LITERATURE, SUPPORT GROUP INFORMATION AND MORE. MTF VOLUNTEER GROUPS COMPRISED OF DONOR FAMILY MEMBERS AND BIRTH TISSUE DONORS WHO SHARE THEIR STORIES AND ENCOURAGE OTHERS TO CONSIDER DONATION. MANY FAMILIES HAVE FOUND THAT BEING INVOLVED WITH OTHER DONOR FAMILIES HAS A PROFOUND EFFECT ON THEIR LIVES AND APPRECIATE THE OPPORTUNITY TO SHARE THE STORY OF THEIR LOVED ONES. TISSUE RECIPIENTS HAVE INSPIRATIONAL STORIES OF HOW A TRANSPLANT TRANSFORMED THEIR LIVES. OUR VOLUNTEERS ARE LOCATED THROUGHOUT THE COUNTRY. WE CAN PROVIDE YOU WITH INFORMATION ON HOW YOU CAN GET INVOLVED AND VOLUNTEER BY CONTACTING VOLUNTEERS@MTF.ORG. THE LINKING LIVES PROGRAM IS A VOLUNTARY PROGRAM THAT GIVES TISSUE RECIPIENTS THE OPPORTUNITY TO WRITE A LETTER OF THANKS TO THEIR DONOR FAMILY. RECIPIENTS ARE ENCOURAGED TO WRITE A LETTER WHICH MTF WILL FORWARD TO THE AGENCY THAT COORDINATED THE TISSUE RECOVERY. WE PROVIDE TISSUE RECIPIENTS WITH GUIDELINES FOR WRITING TO THEIR DONOR FAMILY. THE RECOVERY AGENCY SENDS THE LETTER TO THE DONOR FAMILY. DONOR FAMILIES MAY NOT HEAR FROM THEIR TISSUE RECIPIENTS AS MANY PATIENTS ARE UNAWARE THAT THEY CAN WRITE TO THEIR DONOR FAMILIES. HOWEVER, THOSE WHO DO RECEIVE A LETTER FROM A GRATEFUL TISSUE RECIPIENT HAVE SHARED HOW IMPORTANT THOSE LETTERS CAN BE. FORM 990, PAGE 2, PART III, LINE 4A MTF IS A GLOBAL NONPROFIT ORGANIZATION FOCUSED ON SAVING AND HEALING LIVES, EXPANDING INNOVATION POTENTIAL, HONORING DONATED GIFTS AND SERVING PATIENTS. MTF CONTINUES TO PROVIDE RESEARCH TISSUE AND GRANT FUNDING FOR RESEARCH AND DEVELOPMENT PERFORMED BY ACADEMIC CENTERS AND PIONEERING ENTERPRISES. IN 2023 MTF CONTINUED TO PURSUE ITS MISSION, AND MADE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS THROUGH BOTH INTERNAL AND EXTERNAL DISTRIBUTION RELATIONSHIPS. MTF ORTHOPEDICS FOSTERED NEW PARTNERSHIPS AND EXPANDED ITS REACH BY LAUNCHING MULTIPLE NEW TISSUE FORMS IN 2023. THESE INNOVATIONS POSITIONED THE FOUNDATION AND OUR PARTNERS TO HELP MORE PATIENTS, WHILE FURTHER MAXIMIZING THE GIFT OF DONATION. MTF ALSO IMPLEMENTED PROCESS EFFICIENCIES THAT WILL CONTINUE TO UTILIZE THE GIFT OF DONATION AND ALLOWS OUR SURGEON COLLABORATORS TO ELEVATE THEIR CONTINUUM OF CARE. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY DIVISION, MTF CONTINUED TO INNOVATE IN PLASTIC SURGERY, WHILE PROVIDING SURGEON EDUCATION AND TRAINING. CONTINUED FOCUS WAS PLACED ON PROCESSING EFFICIENCIES AND DONOR RECOVERY METHODS TO MAXIMIZE THE GIFT OF DONATION WITH THE HELP OF ORGAN PROCUREMENT ORGANIZATIONS. MTF CONTINUED TO BOLSTER ITS INTER-INDUSTRY PARTNERSHIPS, INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE DIVISION CONTINUED GROWING THROUGHOUT 2023, EXPANDING ITS PRESENCE IN THE WOUND HEALING SPACE. MTF GENERATED MORE CLINICAL EFFICACY DATA, AS WELL AS HEALTH CARE ECONOMIC DATA FOR EXPANDED REIMBURSEMENT IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY AND VALUE OF ITS TISSUE FORMS. OUR GOAL IS SIMPLE-DO WHAT'S RIGHT FOR PATIENTS, SURGEONS, TISSUE DONORS, AND THEIR FAMILIES THROUGH OUR GUIDING PRINCIPLES: WE TRANSFORM BY PROVIDING SAFE, HIGH-QUALITY GRAFTS FROM DONATED HUMAN TISSUES THAT ARE USED IN A GROWING ARRAY OF CLINICAL FIELDS. WE COLLABORATE BY FORGING RELATIONSHIPS WITH EXPERTS IN TISSUE AND ORGAN RECOVERY, AS WELL AS LEADING PHYSICIANS AND SCIENTISTS, TO ACCELERATE INNOVATION AND ENSURE THE BEST POSSIBLE EXPERIENCES AND OUTCOMES FOR PATIENTS. WE INNOVATE BY ADVANCING THE SCIENCE OF TRANSPLANTATION BY SUPPORTING RESEARCH WITHIN OUR OWN ORGANIZATION AND AMONG CLINICIANS AND RESEARCHERS WORLDWIDE. WE GIVE BACK BY REINVESTING IN RESEARCH TO POSITIVELY AFFECT LIVES ACROSS THE GLOBE. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 170,000 DONORS. IN 2023, MTF RECOVERED TISSUE FROM OVER 5,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 7,500 DONORS FOR USE IN GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 800 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 800 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED OVER 550,000 UNITS OF ALLOGRAFT TISSUE DURING 2023. MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS. FORM 990, PART V, LINE 4B CANADA FORM 990, PAGE 6, PART VI, LINE 4 TO BE DETERMINED. FORM 990, PAGE 6, PART VI, LINE 6 MTF IS ORGANIZED WITH TWO CLASSES OF MEMBERSHIP WHICH ARE (1) NON- CORPORATE MEMBERSHIP AND (2) CORPORATE MEMBERSHIP. THE NON-CORPORATE MEMBERS INCLUDE ACADEMIC MEMBERS, RECOVERY MEMBERS AND RESEARCH MEMBERS. THE SOLE CORPORATE MEMBER OF MTF IS BIOCON, INC. FORM 990, PAGE 6, PART VI, LINE 7A THE SOLE CORPORATE MEMBER MAY APPOINT ALL DIRECTORS SUBJECT TO THE FOLLOWING: THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "MEDICAL BOARD OF TRUSTEES" WILL BE APPOINTED TO THE BOARD. ALSO, THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "DONATION BOARD OF TRUSTEES" WILL BE APPOINTED MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PAGE 6, PART VI, LINE 7B ANY CHANGES THAT ARE A MATERIAL CHANGE TO THE GOVERNING DOCUMENTS OF THE FOUNDATION (EX.BY-LAWS OR ARTICLES OF INCORPORATION) MUST BE APPROVED BY THE MEMBERS OF THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND THE DONATION BOARD OF TRUSTEES. FINAL APPROVAL OF THESE CHANGES MUST BE APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PAGE 6, PART VI, LINE 11B MEMBERS OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS WERE PROVIDED WITH A COPY OF FORM 990. THE 990 WAS REVIEWED AT AN OPEN MEETING OF THE AUDIT COMMITTEE. SUBSEQUENT TO MODIFICATIONS, IF ANY, AS A RESULT OF THE AUDIT COMMITTEE MEETING, THE FORM 990 IS THEN CIRCULATED TO ALL MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR FINAL REVIEW AND APPROVAL BEFORE FILING. FORM 990, PAGE 6, PART VI, LINE 12C MTF SENDS A COMPREHENSIVE QUESTIONNAIRE ANNUALLY TO BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES REQUESTING DISCLOSURE OF ANY CONFLICTS OF INTEREST. MTF IS DILIGENT IN REVIEWING THE ANNUAL DISCLOSURE FORMS SUBMITTED BY THE COVERED PERSONS, AND IN SCREENING, COMPILING AND MAINTAINING THE SUBMISSIONS. FORM 990, PAGE 6, PART VI, LINE 15A EXECUTIVE COMPENSATION REVIEW: EACH YEAR, MTF REVIEWS AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR OUR EXECUTIVE TEAM, INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA, LAST COMPILED IN JULY 2023, FORM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT-FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR (MOST RECENTLY JULY 2023), MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW: MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE INCLUDES THE REVIEW AND APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND BENEFITS. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANNUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED. FORM 990, PAGE 6, PART VI, LINE 15B THE PROCESS IS THE SAME AS DESCRIBED ABOVE IN LINE 15A. FORM 990, PAGE 6, PART VI, LINE 19 MTF MAKES ITS FORM 990 AND OTHER PUBLIC DOCUMENTS AVAILABLE TO THE PUBLIC AT ITS REGULAR PLACE OF BUSINESS IN PERSON, REQUESTS THROUGH EMAIL OR VIA US POSTAL SERVICE. IN ADDITION FORM 990 IS AVAILABLE ON THE INTERNET AT WWW.GUIDESTAR.ORG. FORM 990, PART XI, LINE 9 UNREALIZED FOREIGN EXCHANGE 54,000 UNREALIZED GAIN 1,132,363 GRANTS PAID 88,182 TOTAL 1,274,545 BIOCON INC 125 MAY STREET EDISON NJ 08837 223619257 HOLDING CO DC 501C3 12B NA false DEUTSCHES INSTITUT FUR ZELL- UND C/O BIOCON INC 125 MAY STREET EDISON NJ 08837 TISSUE DIS GM BIOCON INC false DEUTSCHES INSTITUT FUR ZELL-UND C/O BIOCON INC 125 MAY STREET EDISON NJ 08837 TISSUE DIS N/A false true false false true false false true true false false true true false false false false false false true DIZG GMBH A 9572 ACCTG BOOKS/RECORDS DIZG GMBH G 420000 ACCTG BOOKS/RECORDS DIZG GMBH S 451863 ACCTG BOOKS/RECORDS DIZG GMBH D 1802480 ACCTG BOOKS/RECORDS BIOCON INC K 3848761 ACCTG BOOKS/RECORDS BIOCON INC L 572043 ACCTG BOOKS/RECORDS BIOCON INC S 417467 ACCTG BOOKS/RECORDS BIOCON INC D 4003675 ACCTG BOOKS/RECORDS BIOCON INC H 802375 ACCTG BOOKS/RECORDS BIOCON INC A 145034 ACCTG BOOKS/RECORDS SCHEDULE R BIOCON INC, A TAX-EXEMPT ORGANIZATION SERVES AS THE SOLE CORPORATE MEMBER OF MTF. BIOCON THROUGH ITS DISREGARDED ENTITIES OWNS OPERATES AND LEASES PROPERTY TO MTF. SCHEDULE R, PART II AND PART IV: DIZG, GMBH HAS BEEN DETERMINED TO HAVE SOME TAX-EXEMPT ACTIVITIES AS WELL AS SOME TAXABLE ACTIVITIES IN GERMANY. THUS, DIZG IS SHOWN AS BOTH AN EXEMPT AND TAXABLE ORGANIZATION ON SCHEDULE R. DIZG IS A BROTHER/SISTER ENTITY RELATIVE TO MTF AND LIKE MTF IS WHOLLY OWNED BY BIOCON, INC. SCHEDULE R, PART V, LINE 2(1) - 2(4): DURING 2023, DIZG REIMBURSED MTF INTEREST AND PRINCIPAL OF 9,572 AND 451,863, RESPECTIVELY; MTF DISTRIBUTED DONORS TO DIZG IN THE AMOUNT OF 420,000 AND MTF LOANED DIZG 1,802,480. GIVEN THESE CIRCUMSTANCES NO FORM 926 WAS DEEMED NECESSARY.